MD Anderson Announces Collaboration with Johnson & Johnson Innovation on cancer immunotherapy

The University of Texas MD Anderson Cancer Center  will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech, Inc., to develop immunology-based cancer treatments through the MD Anderson Moon Shots Program immunotherapy platform.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news